Presentation TCT 2017 Ventricular Partitioning Approaches: Surgical and Device-Based Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Jozef Bartunek October 31, 2017
Presentation TCT 2017 Potential for Renal Denervation to Treat Chronic Systolic Heart Failure: REACH and More Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Justin E. Davies October 31, 2017
Presentation TCT 2017 State-of-the-Art Overview: Device-Based Therapies for CHF Presenter: Daniel Burkhoff, JoAnn Lindenfeld October 31, 2017
Presentation TCT 2017 CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles October 31, 2017
Presentation TCT 2017 Can Functional Testing for Ischemia and Viability Guide Revascularization in Heart Failure? Presenter: Daniel Burkhoff, JoAnn Lindenfeld, James E. Udelson October 31, 2017
Presentation TCT 2017 Coronary Revascularization for CHF: Implications From STICH for Complete Revascularization Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Eric Jose Velazquez October 31, 2017
Presentation TCT 2017 US and EU Guidelines for Drug and Device Management of Heart Failure: Overview, Similarities, and Differences Presenter: Daniel Burkhoff, JoAnn Lindenfeld, William T. Abraham October 31, 2017
Presentation TCT 2017 Diagnosis and Treatment Options for RV Shock Presenter: Vladimir Dzavik, Navin K. Kapur, James A. Goldstein October 31, 2017
Presentation TCT 2017 First of the Class: Tissue Engineering Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent October 31, 2017
Presentation TCT 2017 Cardiogenic Shock in the Elderly: Rational Treatment Suggestions Presenter: Vladimir Dzavik, Navin K. Kapur, Jose M. de la Torre Hernandez October 31, 2017
Presentation TCT 2017 New Strategies for a Chronic Scenario: Combinative Approaches Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel October 31, 2017
Presentation TCT 2017 Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding October 31, 2017
Presentation TCT 2017 New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry October 31, 2017
Presentation TCT 2017 New Targets: Heart Failure With Preserved Ejection Fraction Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani October 31, 2017
Presentation TCT 2017 Acute Cardiogenic Shock: The Case for First-line Use of ECMO Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol October 31, 2017
Presentation TCT 2017 Case #5: Stent Failure After Multiple Interventions Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Ricardo Santos October 31, 2017
Presentation TCT 2017 Acute Cardiogenic Shock: The Case for First-line Use of Impella Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson October 31, 2017
Presentation TCT 2017 In Which Direction is Cell Based Heart Failure Therapy Headed? Presenter: Francisco Fdez-Aviles, Emerson C. Perin October 31, 2017
Presentation TCT 2017 Acute Cardiogenic Shock: The Case for First-line Use of IABP Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran October 31, 2017
Presentation TCT 2017 Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy? Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem October 31, 2017